Boundless Bio, Inc. (NASDAQ:BOLD) IPO
IPO
Priced at US$16.00 a share on Mar 27, 2024.
- Price
- US$16.00 a share
- Shares offered
- 6,250,000 shares of common stock
- Offering size
- US$100 million
- Underwriters' option
- Up to 937,500 more shares
- Underwriters
- Goldman Sachs & Co. LLC, Leerink Partners, Piper Sandler, Guggenheim Securities · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 1, 2023 |
| Filed publicly | Mar 6, 2024 |
| Amended once | Mar 21, 2024 |
| Shares registered with an exchange | Mar 22, 2024 |
| Declared effective by the SEC | Mar 27, 2024 |
| Final prospectus, with the price | Mar 28, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 28, 2024 |
| EFFECT · Notice that a registration is effective | Mar 27, 2024 |
| CERT · Exchange's certificate of listing | Mar 27, 2024 |
| CORRESP · Letter to the SEC | Mar 25, 2024 |
| CORRESP · Letter to the SEC | Mar 25, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 22, 2024 |
| S-1/A · Registration statement, amended | Mar 21, 2024 |
| CORRESP · Letter to the SEC | Mar 15, 2024 |
| UPLOAD · Letter from the SEC | Mar 13, 2024 |
| CORRESP · Letter to the SEC | Mar 8, 2024 |
| CORRESP · Letter to the SEC | Mar 6, 2024 |
| S-1 · Registration statement | Mar 6, 2024 |
| UPLOAD · Letter from the SEC | Jan 29, 2024 |
| DRS/A · Draft registration statement, amended | Jan 23, 2024 |
| DRSLTR · Letter to the SEC with a draft | Oct 11, 2023 |
| DRS/A · Draft registration statement, amended | Oct 11, 2023 |
| UPLOAD · Letter from the SEC | Sep 29, 2023 |
| DRS · Draft registration statement | Sep 1, 2023 |
From the cover of the final prospectus (424B4) filed Mar 28, 2024